58 results
8-K
EX-1.1
ATXS
Astria Therapeutics Inc
4 Mar 24
Entry into a Material Definitive Agreement
5:22pm
. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory … equity transaction.
(tt) Compliance with Health Care Laws. The Company and its subsidiaries are, and at all times have been, in compliance with all
8-K
EX-1.1
ATXS
Astria Therapeutics Inc
31 Jan 24
Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
9:00am
. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory … ) Compliance with Health Care Laws. The Company and its subsidiaries are, and at all times have been, in compliance with all Health Care Laws in all material
8-K
EX-1.1
cw8wlabw
12 Oct 23
Astria Therapeutics Announces Pricing of $64 Million Underwritten Offering
5:04pm
8-K
EX-1.1
mtp85z ih
15 Dec 22
Astria Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
5:18pm
8-K
EX-1.1
1ax feyif07xkxtvu1
30 Jun 21
Entry into a Material Definitive Agreement
4:25pm
D
vbiqo69b1w
8 Feb 21
$110.01M in equity, sold $110.01M, 23 investors
4:54pm
D
3sf1axv glw4ym7
8 Feb 21
$175.74M in equity / options / securities to be acquired, sold $175.74M, 6 investors
4:51pm
8-K
EX-2.1
jvetjt
29 Jan 21
Entry into a Material Definitive Agreement
8:05am